Sandler Laura Lee (CIK 2075401) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Sell ORKA (906 shares), Buy ORKA (5,000 shares), Sell ORKA (1,000 shares), Sell ORKA (4,000 shares), Buy ORKA (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 906 | $86,713 |
| 2026-09-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-09-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 1,000 | $91,048 |
| 2026-09-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 4,000 | $368,054 |
| 2026-07-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-07-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 2,237 | $209,933 |
| 2026-07-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 2,263 | $214,410 |
| 2026-07-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 500 | $47,736 |
| 2026-06-15 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 600 | $41,814 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 300 | $19,530 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 2,200 | $137,676 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 1,800 | $115,470 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 400 | $26,424 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 200 | $13,432 |
| 2026-05-01 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 100 | $6,848 |
| 2026-03-17 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 600 | $24,780 |
| 2026-03-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-03-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 2,325 | $77,376 |
| 2026-03-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 2,675 | $90,442 |
| 2026-01-23 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 32,500 | $0 |
| 2026-01-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Buy | 5,000 | $39,000 |
| 2026-01-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 8,748 | $246,431 |
| 2026-01-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 3,144 | $91,428 |
| 2026-01-02 | Oruka Therapeutics, Inc. (ORKA) | Chief Operating Officer | Sell | 1,108 | $32,963 |
Source: SEC Form 4 filings · as of 2026-09-15